Mesenteric lymph pathway serves as the primary route by which gut injury leads to systemic inflammation and distant organ injury. The inflammation of the intestinal tract is partially mediated by vasoactive intestinal peptide (VIP). Therefore, the aim of this study was to test whether exogenous VIP affects mesenteric lymph pathway during early intestinal ischemia-reperfusion (IIR) injury. Rats were randomized into control, control + VIP, IIR and IIR + VIP groups. The observation of mesenteric lymph flow was carried out by cannulation of mesenteric lymphatics. The distribution of in vivo lymphocyte trafficking was performed by 51 Cr labeled lymphocytes and was measured by γ-counter. Endotoxin concentration was assayed using the limulus test kit and TNF-α level was detected by ELISA. When IIR injury treated with VIP, the volumes of lymph flow increased by 80%, which caused the number of lymphocytes exiting in mesenteric lymphatic increased by 50% while the proportion of 51 Crlymphocytes in Peyer's patches, intestinal effector tissues, mesenteric nodes, large intestine, stomach decreased by 58%, 51%, 58%, 63%, 64% respectively at the 6th h after reperfusion following intestinal ischemia. Meanwhile, endotoxin and TNF-α levels in intestinal lymph decreased by 51% and 83%. These results suggest that exogenous VIP ameliorates IIR induced splanchnic organ damage via inhibition of toxic mediators reaching systemic circulation and reinforcement of the effective immune responses in gut-associated lymphoid tissues (GALT).
Introduction
Vasoactive intestinal peptide (VIP) is a 28-amino acid peptide belonging to the members of a superfamily of structurally related peptide hormones with a broad range of biological activities [1] . It has been found in high concentrations both in the central nervous system and gastrointestinal tract [2] . Many studies have reported that VIP plays an important role in immune regulation [3] [4] [5] in an anti-inflammatory manner [6, 7] , including inhibition of the endotoxin induced TNF-α production by macrophages [8] , the release of IL-6 from macrophages stimulated with high lipopolysaccharide doses [9] , and the expression and secretion of IL-2, IL-4, and IL-10 in stimulated peripheral T cell [10] . In addition, VIP attenuates small intestinal microcirculation and mucosal injury after hepatic ischemia-reperfusion (IR) [11] , hepatic microvasculatory disturbances following intestinal IR (IIR) [12] , and IR injury in orthotopic mouse lung transplants [13] , However, the exact mechanism is still unknown.
IIR injury occurs in various clinical critical illnesses leading to high morbidity and mortality [14, 15] . It triggers an intense inflammatory response that results systemic inflammatory response syndrome (SIRS) and even multiple organ dysfunction syndrome (MODS) [15] [16] [17] . During IIR injury, various injurious toxic mediators produced in ischemic areas enter the circulation and lead to distant organ (including the lung, liver, heart and kidney) damage [18, 19] . Mesenteric lymph pathway (i.e., mesenteric lymph leaving mesenteric efferent lymphatic enters the subclavian vein via the thoracic duct, which, in turn, empties directly into other organs) serves as the primary route for the injurious gut-derived toxic factors, which can induce SIRS and MODS [20, 21] . These toxic factors have been demonstrated in mesenteric lymph, but not in the systemic or portal circulation [22] . Additionally, the continual trafficking of numerous activated intestinal lymphocytes from mesenteric lymph to systemic circulation are to ensure antigenic encounter and the triggering of the effective immune responses [23, 24] . Therefore, mesenteric lymph pathway plays a more crucial role from IIR injury to SIRS and even MODS. To our knowledge, there are no data available regarding the roles of mesenteric lymph pathway in the effects of VIP on IIR injury.
The objectives of the present study are to observe the effects of VIP on the disorders of mesenteric lymph flow and in vivo intestinal lymphocyte trafficking and the levels of certain gut-derived toxic factors in the mesenteric lymph after IIR injury, and to highlight on the role of VIP in IIR induced splanchnic organ dysfunction in view of the interaction between gut peptides and mucosal immunity.
Materials and methods

Experimental grouping and VIP treatment
Forty-eight healthy adult male Wistar rats weighing 250-300g were provided by the experimental animal center of Nanjing Medical University, China. The following experimental groups were included in this study: 1) normal control (sham-operation) group1 (n = 6), 2) control + VIP group1 (n = 6), 3) IIR group1 (n = 6), 4) IIR + VIP group1(n = 6), 5) normal control group2 (n = 6), 6) control + VIP group2(n = 6), 7) IIR group2 (n = 6), and 8) IIR + VIP group2 (n = 6). In group1, the volumes of mesenteric lymph and the number of intestinal lymphocytes output in the mesenteric lymphatic at the 6th h after reperfusion were observed and in group2, 51 Cr labeled intestinal lymphocytes in vivo trafficking in vital organs at the same period of time were countered. VIP-28 (Calbiochem, EMD Bioscience, La Jolla, CA, USA) was given to femoral vein of rats at a dosage of 0.2 ρmol/g/h from 30 min before occlusion of the superior mesenteric artery (SMA) until the end of the experiment with a syringe pump (B. Braun Co. Germany) combined with intraperitoneal injection at a dosage of 0.25 ρmol/g from 30 min, 0 min before occlusion of the SMA and 120 min, 240 min after occlusion of the SMA. In the control group or the IIR group, 0.9% saline water instead of VIP was injected into femoral vein of rats according to the same procedure as rats with VIP treatment. All procedures using animals were reviewed and approved by the Experimental Animal Review Board of Nanjing Medical University and were performed according to the criteria outlined by the National Ministry of Health.
Surgical procedure
The superior mesenteric artery (SMA) of rats in the IIR group was ligated with a small clamp until complete ischemia of SMA for 45 min. Upon release of the clamp, the rats were allowed recovering from anesthesia for 6 h. After reperfusion, the rats were sacrificed under deep isoflurane anesthesia. In the normal control group, the SMA was isolated without clamping and was exposed to the same procedure as rats with SMA occlusion.
Mesenteic lymph collection and lymphocytes counting
The procedures used to collect the mesenteric lymph in rats have been described previously [25] . Briefly, the rats were anesthetized with amobarbital by intraperitoneal injection. A midline celiotomy incision was made and the mesenteric lymphatic identified (adjacent to the SMA) by reflecting the loops of intestine to the left of the animal with a metal hook. A plastic tube, 1 mm in diameter, with beveled ends, was passed into the mesenteric lymphatic and the lymph begins to flow immediately through the tubes. The lymphatic was divided with visible confirmation of free flow of lymph into a centrifuge tube. After collection stopped, the mesenteric lymph was measured and lymphocytes were counted under light scope.
T and B lymphocytes counting in mesenteric lymph
Intestinal lymphocytes were collected as described above. Cell viability was determined by 0.2% Evans blue staining. More than 95% of the cells were viable for measurement of lymphocyte subsets. CD3T, CD20 B lymphocyte subsets were analyzed by flow cytometry.
Determination of in vivo lymphocyte trafficking
In group2, mesenteric lymph was collected for 1 h in the 4th h after reperfusion. Then, the lymphocytes collected from mesenteric lymphatic were labeled with 51 Cr and infused into femoral vein of rats at the beginning of the 6th h after reperfusion. 1 h later, the rats were killed, small intestines containing 51 Cr-intestinal lymphocytes and other vital organs were removed and counted with γ-counter. Cr]O 4 for 1 h at 37°C in water. After incubation, the liquid was centrifuged at 500 g for 5 min, then the supernatant was decanted and the remainder was added into a test tube containing 100% fetal bovine serum and 17% Nycodenz (Sigma Co. USA). The mix liquid was centrifuged at 1200 g for 5 min. The
51
Cr labeled lymphocytes were collect from the layer between fetal bovine serum and Nycodenz. 5 × 10 6 51
Cr-lymphocytes mixed with 0.4 mL of RPMI-1640 were infused slowly into the femoral vein of rats. 1 h later, rats were killed and the small intestines and other vital organs were removed and 1 mL of blood sample was taken from heart puncture. The organs containing 51 Cr labeled lymphocytes were measured by γ-counter (TDC-601, Aloka Co, Japan) [26] . The total counts of the 1 × 10 7 lymphocytes were measured and lymphocyte populations in the intestine and other organs were calculated as a background corrected percentage of counts per organ over the total counts.
Functinonal evaluation of vital organs
Peripheral blood was taken from rats in each group before they were killed to determine the oxygen partial pressure (PaO 2 ) with DMNI modular system (AVL, Graz, Austria), alanine aminotransferase (ALT), and creatinine level (AUOLYMPUS5400; Olympus, Tokyo, Japan). Plasma D-lactate concentration was measured by an enzymatic spectrophotometric assay using a centrifugal analyzer at 30°C (Hoffmann-LaRoche, Basle, Switzerland) as described earlier [27] . D-lactate, D-lactate dehydrogenase and NAD + were purchased from Sigma Chemical Company (USA).
Measurement of endotoxin concentration and TNF-α activity
Endotoxin concentration in plasma or mesenteric lymph was assayed using the limulus test kit (Yihua Clinical Technology Co, Shanghai, China). The assay depends on bacterial endotoxin to activate a proenzyme in the limulus amoebocyte lysate that catalyzes the cleavage of p-nitroaniline (pNA) from the colorless substrate. The pNA is assayed spectrophotometrically at 545 nm and provides a quantitative analysis of endotoxin content. TNF-α concentration in serum and mesenteric lymph was determined by using rat TNF-enzyme-linked immunoabsorbent assay (ELISA) kit (LIFEKEY Biotech, Co. USA) according to manufacturer's protocol.
Morphological changes of the gut and injury score
Specimens from the small intestines (5 cm from the distal end of ileum) were taken out and fixed with 10% formaldehyde. The paraffin sections were stained with hematoxylin and eosin for histological evaluation in a single blinded fashion. For semiquantitative evaluation of lesions, 10 arbitrary microscopic fields were viewed in each sample. The scoring system was based on area of the lesion: +, b 1/3 total area; ++, 1/3-2/3 total area; +++, N 2/3 total area.
Statistical analysis
All data were expressed as the means ± standard deviation (SD). Statistical analysis was performed by one-way ANOVA with Fisher's test. Difference was considered statistically significant when p b0.05.
Results
Pathological changes of the intestine and injury score
During IIR injury, the intestinal villi were loosened and atrophic where the epithelial cells were necrotic. The mucosa was edematous and infiltrated with inflammatory cells (Fig. 1B) . Semiquantitative evaluation was scored as ++. After IIR injury treated with VIP, the intestinal mucosa and the villi recovered completely. Semiquantitative evaluation was scored as +.
Functinal changes of vital organs or tissues
After IIR injury treated with VIP, plasma D-lactate, ALT and creatinine levels decreased by 57% ( Fig. 5 ) compared with those in IIR group2.
Discussion
Clinical care illnesses including shock, infection, severe acute pancreatitis, and organ transplantation are susceptible to IIR injury [28] . Reperfusion of the intestine subjected to ischemia or hypoperfusion of intestinal tissues results in an increase in intestinal inflammation and loss of intestinal barrier function as the initial triggering events that contribute to the development of SIRS [29, 30] . However, inflammation of the intestinal tract may be partially mediated by gut peptides or neurotransmitters [31, 32] . VIP exerts therapeutic effects by acting as a potent anti-inflammatory factor in many different disease models, including septic shock, inflammatory bowel disease, and acute lung injury [33] [34] [35] . After IIR injury treated with VIP, the significant improvements of pathological changes were observed in this study. This finding suggests that VIP reduces the severity of intestinal histopathologic changes (Fig. 1) . Additionally, the plasma D-lactate levels decreased after intravenous injection combined with intraperitoneal injection of VIP in rats subjected to IIR injury (Fig. 2) . D-lactate is produced by bacteria of the gastrointestinal tract and is absorbed in the small intestine and colon and plasma and is a sensitive marker for gut barrier failure [27] . This indicates that VIP promotes the recovery of intestinal barrier function. Meanwhile, the plasma aminoleucine transferase (ALT) and creatinine levels decreased and blood PaO 2 pressure increased (Fig. 2) . It suggests that VIP improveds the functional damage of the liver, the kidney and the lung.
Gut-derived factors carried in the mesenteric lymph as the source of factors leading to lung and heart injuries as well the induction of SIRS after burn injury or trauma-hemorrhage [36, 37] . However, the exact factors responsible for triggering this inflammatory cascade leading to remote organ dysfunction have not been known completely [38] . Evidences indicate that gut-derived endotoxin and TNF-α are the important mediators involved in activating the inflammatory reactions and potentiate the development of MODS [38, 39] . After IIR injury treated Fig. 1 . The obvious improvement of histologies was observed in the rats subjected to IIR treated with VIP(C). Histological changes of ileum from three groups (hematoxylin and eosin stain, ×100). Representative slide from the intestinal tissues (5 cm from the distal end of the ileum) of rats subjected to IIR (B) or IIR treated with VIP (C) or sham operation (A) were visualized and captured under a light microscope.
with VIP, the endotoxin levels in intestinal lymph and plasma significantly decreased while the TNF-α levels in intestinal lymph and serum decreased at the 6th h after reperfusion compared with those in IIR group in this study (Fig. 3) . This suggests that VIP can suppress an increased inflammatory response caused by IIR injury via inhibition of endotoxin generation and TNF-α production.
The mesenteric lymph microcirculation forms an important route to return the lymph from gut-associated lymphoid tissues (GALT) to blood circulation. In the clinical setting, mesenteric lymph pathway can be disrupted by many different causes including infection, trauma, surgery, shock, and radiation [18] . Meanwhile, lymphocytes, particularly T cells have an important role during IIR injury. There are evidences showed that significant T-cell adhesion in mucosal venule of the postischemic intestine was noted at the 6th h after reperfusion [40] . Fukatsu K et al. [41] demonstrated that IIR significantly reduced the number of intestinal intraepithelial lymphocytes and lymphocytes in Peyer's patches (PP) and the lamina propria (LP). During IIR injury, the number of intestinal lymphocytes exiting in mesenteric efferent lymphatic at the 6th h after mesenteric reperfusion significantly decreased (predominantly T cells) compared with those in control group, which caused by the reduced mesenteric lymph flow at the same period of time as a result of hypoperfusion of the ischemic intestinal tissues and the decreased number of intestinal lymphocytes per milliliter because of reduction in generation of lymphocytes in the ischemic GALT (Fig. 4) . The reduced volumes of lymph flow and the decreased intestinal lymphocytes exiting in mesenteric efferent lymphatic at the 6th h of reperfusion as an early response to IIR injury showed the disturbances of the mesenteric lymph after reperfusion. Furthermore, we deduce that the number of intestinal lymphocytes migration from blood circulation to gastroenteric tract will decrease as a result of the reduced number of lymphocytes exiting in mesenteric efferent lymphatic. However, the proportion of 51 Cr-intestinal lymphocytes in gastroenteric tract significantly increased at the same period of time (Fig. 5) . A possible explanation for the fact that IIR-induced increase in the proportion of 51 Crlymphocytes in digestive tract may be considered as a compensatory response for the limitation of the intestinal lymphocytes recirculation back through GALT and may not increase the overall number of intestinal lymphocytes migration from systemic circulation to gastrointestinal mucosa and improve the mucosal immune function. When IIR injury treated with VIP, although the number of intestinal lymphocytes per milliliter had no changes, the volumes of lymph flow at the 6th h after mesenteric reperfusion obviously increased, which caused the number of intestinal lymphocytes output significantly increased (Fig. 4) Meanwhile, the proportion of 51 Cr-lymphocytes in PP, intestinal effector tissues (including IEL and LP), mesenteric nodes, large intestine, and stomach sharply decreased compared with those in IIR group (Fig. 5) . For this observation, we may speculate that VIP prevents gut-derived toxic mediators reaching the systemic circulation because of the endotoxin and TNF-α concentration in mesenteric lymph markedly decreased (Fig. 3) , although the volumes of mesenteric lymph flow at the 6th h after mesenteric reperfusion enhanced by VIP increase the amount of these toxic factors reaching system circulation, which is not relatively dominant compared with their obvious reduction in the mesenteric lymph. On the other hand, intestinal lymphocytes reaching blood circulation and in turn homing to the effector sites of GALT including IEL and LP increased due to the number of lymphocytes exiting in mesenteric lymphatic at the 6th h after reperfusion in mesenteric efferent lymphatic increased by VIP. This indicates that VIP enhances the effective responses of gastroenteric tract as a result of the increased number of intestinal lymphocytes generated from GALT to systemic circulation and in turn homing to gastroenteric tract during early IIR injury, while the decreased proportion of 51 Cr-intestinal lymphocytes migration to gastroenteric tract after IIR injury treated with VIP does not have a more crucial effect on these changes.
Mesenteric lymph pathway is an important bridge by which IIR injury leads to SIRS and even MODS. VIP ameliorates intestinal inflammatory responses to IIR and improves the splanchnic organ function associated with mesenteric lymph pathway. This study emphasizes the need to better understand the important roles of mesenteric lymph pathway in protective effects of VIP on IIR induced multiple organ dysfunctions in rats. After IIR injury treated with VIP, the endotoxin and TNF-α levels in mesenteric lymph were overall low and the number of intestinal lymphocytes output in mesenteric efferent lymphatic obviously increased at the 6th h after reperfusion, suggesting that a suppression of gut-derived toxic mediators reaching the systemic circulation and reinforcement of the effective immune responses in GALT may need to be very aggressive to have beneficial effects and ameliorate IIR induced splanchnic organ damage at the early stage of IIR injury.
